Insider investments, especially those disclosed through 13D filings, are closely watched by investors as they often indicate insider confidence in the company's future prospects. Stavros G. Vizirgianakis's significant stake in Apyx Medical could be perceived positively by the market, potentially leading to a short-term positive impact on the stock price. However, the actual impact would depend on broader market conditions and investor perception of the company's future growth.